Red Light Holland Launches New Logo and Interactive Wisdom Truffle Companion Created by Internationally Renowned & Award-Winning Designer Karim Rashid Post published:March 2, 2021 Post category:Press Release
PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization Post published:March 2, 2021 Post category:Press Release
COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021 Post published:March 2, 2021 Post category:Press Release
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease Post published:March 2, 2021 Post category:Press Release
Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update Post published:March 2, 2021 Post category:Press Release
NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data Post published:March 2, 2021 Post category:Press Release
Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1 Post published:March 2, 2021 Post category:Press Release
MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin Post published:March 2, 2021 Post category:Press Release
Psychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful Completion of Reverse Take-Over Transaction Post published:March 1, 2021 Post category:Press Release
Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter Post published:March 1, 2021 Post category:Press Release